STRATTERA Side Effects

6244711-4 | Anxiety, Fear, Hallucination, Paraesthesia
on Jun 23, 2009 Female patient from UNITED STATES , child 6 years of age, weighting 50.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), fear, hallucination, paraesthesia. Strattera dosage: 10mg 1/day Po.

6242399-X | Hepatitis, Malaise, Nausea, Pain, Urticaria
Patient was taking Strattera (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), malaise, nausea (What is nausea?), pain (What is pain?), urticaria on Jun 22, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 222.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 60mg Qd Po. Patient was hospitalized.

6241757-7 | Blood Bilirubin Increased, Weight Decreased
Adverse event was reported on Jun 10, 2009 by a Male patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 12 years of age, After Strattera was administered, patient had the following side effects: blood bilirubin increased, weight decreased.

6241691-2 | Mood Altered, Morbid Thoughts, Rash, Urinary Hesitation
on Jun 11, 2009 Male patient from UNITED KINGDOM , weighting 84.44 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: mood altered, morbid thoughts, rash (What is rash?), urinary hesitation. Strattera dosage: 60 Mg, Daily (1/d). During the same period patient was treated with EQUASYM (View Equasym Review and Equasym Label ).


6238752-0 |
on Jun 09, 2009 Male patient from UNITED STATES , 65 years of age, was treated with Strattera (View Usage). . Strattera dosage: .

6238689-7 | Angina Pectoris, Nausea
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: angina pectoris, nausea (What is nausea?) on Jun 09, 2009 from CANADA Additional patient health information: Female patient , 13 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 60 Mg, Each Morning. During the same period patient was treated with CONCERTA (36 Mg, Each Morning) (View Concerta Review and Concerta Label ).

6236414-7 |
Adverse event was reported on Jun 08, 2009 by a Male patient taking Strattera (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, .

6234008-0 | Feeling Abnormal, Gun Shot Wound, Intentional Self-injury, Mood Altered, Theft
on Jun 16, 2009 Male patient from UNITED STATES , 19 years of age, weighting 120.0 lb, was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?) and was treated with Strattera (View Usage). Patient had the following side effects: feeling abnormal, gun shot wound, intentional self-injury, mood altered, theft. Strattera dosage: 40 Meg Two A Day.

6233096-5 | Adverse Event, Anger, Blood Pressure Increased, Cardiac Arrest, Mood Swings
on Jun 04, 2009 Male patient from UNITED STATES , weighting 152.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: adverse event, anger, blood pressure increased, cardiac arrest (What is cardiac arrest?), mood swings. Strattera dosage: .

6231952-5 | Anorexia, Depression, Suicidal Ideation
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, depression (What is depression?), suicidal ideation on Jun 03, 2009 from GERMANY Additional patient health information: Male patient , weighting 61.73 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 40 Mg, Daily (1/d).

6229915-9 | Chills, Chromaturia, Constipation, Hepatic Enzyme Increased, Influenza Like Illness, Lethargy, Neck Mass, Ocular Hyperaemia, Ocular Icterus
Adverse event was reported on Jun 01, 2009 by a Male patient taking Strattera (View Usage) (Dosage: 10 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: NEW ZEALAND , child 8 years of age, Patient had the following side effects: chills, chromaturia, constipation (What is constipation?), hepatic enzyme increased, influenza like illness, lethargy, neck mass, ocular hyperaemia, ocular icterus. During the same period patient was treated with VENTOLIN /SCH/ (View Ventolin /sch/ Review and Ventolin /sch/ Label ), BECLAZONE (View Beclazone Review and Beclazone Label ).

6229882-8 | Hospitalisation, Suicidal Ideation
on Jun 02, 2009 Male patient from UNITED STATES , 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: hospitalisation, suicidal ideation. Strattera dosage: 60 Mg, Daily (1/d). Patient was hospitalized.

6229874-9 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
on Jun 02, 2009 Female patient from UNITED STATES , 18 years of age, weighting 144.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Strattera dosage: 18 Mg, Unk.

6228156-9 |
Patient was taking Strattera (View Usage). on Jun 01, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 60 Mg, Daily (1/d). During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PAXIL (View Paxil Review and Paxil Label ), TOFRANIL (View Tofranil Review and Tofranil Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PSEUDOEPHEDRINE HCL (View Pseudoephedrine Hcl Review and Pseudoephedrine Hcl Label ).

6223000-8 | Aspartate Aminotransferase Increased, Asthenia, Blood Creatine Phosphokinase Increased, Chest Pain, Dyspnoea, Liver Function Test Abnormal, Neutropenia
Adverse event was reported on May 28, 2009 by a Male patient taking Strattera (View Usage) (Dosage: ) . Location: UNITED STATES , 65 years of age, After Strattera was administered, patient had the following side effects: aspartate aminotransferase increased, asthenia, blood creatine phosphokinase increased, chest pain (What is chest pain?), dyspnoea, liver function test abnormal, neutropenia. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ZETIA (View Zetia Review and Zetia Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6221208-9 | Blood Bilirubin Increased, Weight Decreased
on May 27, 2009 Male patient from UNITED STATES , child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, weight decreased. Strattera dosage: .

6221206-5 | Benign Prostatic Hyperplasia
on May 27, 2009 Male patient from CANADA , 50 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: benign prostatic hyperplasia. Strattera dosage: . During the same period patient was treated with PROSCAR (View Proscar Review and Proscar Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), SULFATRIM (View Sulfatrim Review and Sulfatrim Label ), NORFLOXACIN (View Norfloxacin Review and Norfloxacin Label ).

6220244-6 | Cardiac Murmur Functional, Electrocardiogram Qt Prolonged, Heart Rate Increased
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: cardiac murmur functional, electrocardiogram qt prolonged, heart rate increased on May 26, 2009 from UNITED STATES Additional patient health information: Male patient , 15 years of age, was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?) and. Strattera dosage: . During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ).

6211413-X | Intentional Self-injury, Suicidal Ideation
Adverse event was reported on May 21, 2009 by a Female patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: AUSTRALIA , weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: intentional self-injury, suicidal ideation. During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ).

6211409-8 | Abdominal Discomfort, Crying, Emotional Disorder, Gastrointestinal Pain
on May 22, 2009 Male patient from UNITED STATES , child 6 years of age, weighting 70.00 lb, was diagnosed with anger and was treated with Strattera (View Usage). Patient had the following side effects: abdominal discomfort, crying, emotional disorder, gastrointestinal pain. Strattera dosage: .

6211392-5 | Agitation, Homicidal Ideation, Schizophrenia
on May 22, 2009 Male patient from GERMANY , 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: agitation, homicidal ideation, schizophrenia. Strattera dosage: 40 Mg, Daily (1/d). During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ).

6208440-5 | Syncope
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: syncope on May 19, 2009 from UNITED STATES Additional patient health information: Female patient , 19 years of age, weighting 130.0 lb, . Strattera dosage: 25 Mg, 2/d. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ).

6206541-9 | Hepatic Enzyme Increased, Hepatic Pain, Liver Disorder
Adverse event was reported on May 20, 2009 by a Male patient taking Strattera (View Usage) (Dosage: 10 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: MEXICO , 14 years of age, weighting 154.3 lb, Patient had the following side effects: hepatic enzyme increased, hepatic pain, liver disorder. During the same period patient was treated with CARBAMAZEPINE (200 Mg, Every 8 Hrs) (View Carbamazepine Review and Carbamazepine Label ), VALPROATE SODIUM (200 Ug, Every 8 Hrs) (View Valproate Sodium Review and Valproate Sodium Label ), RISPERIDONE (2 Mg, Daily (1/d)) (View Risperidone Review and Risperidone Label ).

6206534-1 | Anorexia, Depression, Suicidal Ideation
on May 18, 2009 Male patient from GERMANY , weighting 61.73 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: anorexia, depression (What is depression?), suicidal ideation. Strattera dosage: 40 Mg, Daily (1/d).

6204209-6 | Hepatic Enzyme Increased, Overdose, Suicide Attempt
on May 26, 2009 Female patient from UNITED STATES , 13 years of age, weighting 95.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, overdose, suicide attempt. Strattera dosage: One Each Night Po. Patient was hospitalized.

6203490-7 | Abdominal Pain Upper, Anger, Headache, Somnolence
Patient was taking Strattera (View Usage). Patient had the following side effects: abdominal pain upper, anger, headache (What is headache?), somnolence on May 19, 2009 from UNITED STATES Additional patient health information: Male patient , child 8 years of age, weighting 62.99 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 36 Mg, Daily (1/d).

6202641-8 | Central Nervous System Lesion, Convulsion, Dizziness, Grand Mal Convulsion
Adverse event was reported on May 14, 2009 by a Male patient taking Strattera (View Usage) (Dosage: 50 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: GERMANY , 13 years of age, After Strattera was administered, patient had the following side effects: central nervous system lesion, convulsion, dizziness (What is dizziness?), grand mal convulsion.

6198630-2 | Anorexia Nervosa, Condition Aggravated, Depressed Mood, Eating Disorder, Weight Decreased
on May 13, 2009 Female patient from GERMANY , child 10 years of age, weighting 63.93 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia nervosa, condition aggravated, depressed mood, eating disorder (What is eating disorder?), weight decreased. Strattera dosage: 25 Mg, Daily (1/d). Patient was hospitalized.

6198305-X | Atrioventricular Block First Degree
on May 11, 2009 Male patient from UNITED STATES , 41 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: atrioventricular block first degree. Strattera dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ).

6198304-8 | Aggression, Amenorrhoea, Headache, Vomiting
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: aggression, amenorrhoea, headache (What is headache?), vomiting on May 11, 2009 from GREECE Additional patient health information: Female patient , 46 years of age, was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?) and. Strattera dosage: . During the same period patient was treated with BUPRENORPHINE HCL (View Buprenorphine Hcl Review and Buprenorphine Hcl Label ), LADOSE (View Ladose Review and Ladose Label ).

6198114-1 | Dyskinesia, Neuroleptic Malignant Syndrome
Adverse event was reported on May 01, 2009 by a Female patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 17 years of age, Patient experienced the following unwanted or unexpected effects: dyskinesia, neuroleptic malignant syndrome. Patient was hospitalized.

6195653-4 | Abdominal Pain Upper, Disturbance In Attention, Malaise, Weight Decreased
on May 07, 2009 Male patient from AUSTRALIA , weighting 93.92 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Strattera (View Usage). Patient had the following side effects: abdominal pain upper, disturbance in attention, malaise, weight decreased. Strattera dosage: .

6193813-X | Attention Deficit/hyperactivity Disorder, Dyspnoea, Nausea, Palpitations, Sinus Tachycardia
on May 04, 2009 Female patient from DENMARK , 15 years of age, weighting 97.00 lb, was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?) and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: attention deficit/hyperactivity disorder, dyspnoea, nausea (What is nausea?), palpitations, sinus tachycardia. Strattera dosage: . During the same period patient was treated with FONTEX (View Fontex Review and Fontex Label ). Patient was hospitalized.

6193697-X | Suicidal Behaviour
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: suicidal behaviour on May 06, 2009 from GERMANY Additional patient health information: Male patient , 14 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: . During the same period patient was treated with MEDIKINET (View Medikinet Review and Medikinet Label ).

6193656-7 | Abdominal Pain, Aggression, Hypertension, Renal Artery Stenosis, Tachycardia
Adverse event was reported on May 06, 2009 by a Female patient taking Strattera (View Usage) (Dosage: 18 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: GERMANY , child 12 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), aggression, hypertension, renal artery stenosis, tachycardia. During the same period patient was treated with IBUPROFEN (Unk, As Needed) (View Ibuprofen Review and Ibuprofen Label ).

6193372-1 | Abdominal Pain Lower, Back Pain, Cystitis, Dizziness, Dyspareunia, Ejaculation Disorder, Erectile Dysfunction, Headache, Prostatitis
on May 14, 2009 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: abdominal pain lower, back pain (What is back pain?), cystitis, dizziness (What is dizziness?), dyspareunia, ejaculation disorder, erectile dysfunction (What is erectile dysfunction?), headache (What is headache?), prostatitis. Strattera dosage: 60 Mg Daily Po.

6192908-4 | Dyspnoea, Nausea, Sinus Tachycardia
on May 04, 2009 Female patient from DENMARK , 15 years of age, weighting 97.00 lb, was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?) and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, nausea (What is nausea?), sinus tachycardia. Strattera dosage: . During the same period patient was treated with FONTEX (View Fontex Review and Fontex Label ). Patient was hospitalized.

6192120-9 | Deafness, Therapeutic Response Decreased
Patient was taking Strattera (View Usage). Patient had the following side effects: deafness, therapeutic response decreased on May 04, 2009 from UNITED STATES Additional patient health information: Male patient , child 7 years of age, weighting 49.99 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: .

6192118-0 | Palpitations, Panic Attack
Adverse event was reported on May 05, 2009 by a Male patient taking Strattera (View Usage) (Dosage: 50 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED KINGDOM , 14 years of age, After Strattera was administered, patient had the following side effects: palpitations, panic attack.

6187035-6 | Thinking Abnormal, Tourette's Disorder, Violence-related Symptom
on May 01, 2009 Male patient from UNITED KINGDOM , child 6 years of age, weighting 46.30 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: thinking abnormal, tourette's disorder, violence-related symptom. Strattera dosage: .

6187029-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased
on May 04, 2009 Male patient from CANADA , child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased. Strattera dosage: 60 Mg, Daily (1/d). During the same period patient was treated with EFFEXOR (75 Mg, Each Evening) (View Effexor Review and Effexor Label ), LOVAZA (View Lovaza Review and Lovaza Label ), RISPERIDONE (0.25 Mg, 2/d) (View Risperidone Review and Risperidone Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6186989-1 | Deafness Neurosensory
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: deafness neurosensory on May 08, 2009 from UNITED STATES Additional patient health information: Female patient , child 8 years of age, weighting 79.37 lb, was diagnosed with abnormal behaviour, disturbance in attention and. Strattera dosage: .

6184280-0 | Mydriasis, Vision Blurred
Adverse event was reported on Apr 27, 2009 by a Male patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED KINGDOM , weighting 78.26 lb, Patient experienced the following unwanted or unexpected effects: mydriasis, vision blurred. During the same period patient was treated with EQUASYM (View Equasym Review and Equasym Label ).

6184273-3 | Intentional Overdose, Suicide Attempt, Tachycardia
on Apr 29, 2009 Male patient from UNITED STATES , 17 years of age, weighting 137.0 lb, was diagnosed with attention deficit/hyperactivity disorder, depression (What is depression?) and was treated with Strattera (View Usage). Patient had the following side effects: intentional overdose, suicide attempt, tachycardia. Strattera dosage: 10 Mg, Daily (1/d). During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized.

6181848-2 | Dyspnoea, Erythema, Hyperhidrosis, Pallor, Respiratory Rate Increased, Staring
on Apr 24, 2009 Male patient from UNITED KINGDOM , 13 years of age, was diagnosed with abnormal behaviour and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: dyspnoea, erythema, hyperhidrosis, pallor, respiratory rate increased, staring. Strattera dosage: 25 Mg, Daily (1/d).

6181845-7 | Depression, Psychomotor Retardation, Social Avoidant Behaviour, Tearfulness
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), psychomotor retardation, social avoidant behaviour, tearfulness on Apr 24, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 15 years of age, weighting 158.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 70 Mg, Unk. During the same period patient was treated with CANNABIS (View Cannabis Review and Cannabis Label ), ALCOHOL (View Alcohol Review and Alcohol Label ).

6175858-9 | Abdominal Pain Upper, Abnormal Behaviour, Adverse Event, Headache, Nausea
Adverse event was reported on Apr 23, 2009 by a Male patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: CANADA , weighting 105.0 lb, Patient had the following side effects: abdominal pain upper, abnormal behaviour, adverse event, headache (What is headache?), nausea (What is nausea?).

6175854-1 | Abdominal Pain, Diarrhoea
on Apr 23, 2009 Female patient from UNITED STATES , 35 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea. Strattera dosage: .

6173353-4 | Abdominal Pain, Impaired Gastric Emptying, Nausea
on Apr 22, 2009 Female patient from UNITED STATES , 18 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), impaired gastric emptying, nausea (What is nausea?). Strattera dosage: .

6173351-0 | Diarrhoea, Hallucination, Pyrexia, Vomiting
Patient was taking Strattera (View Usage). Patient had the following side effects: diarrhoea, hallucination, pyrexia, vomiting on Apr 21, 2009 from FINLAND Additional patient health information: Female patient , child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 60 Mg, Daily (1/d). Patient was hospitalized.